Ranaz reports second quarter 2009 financial results

Ranaz Corporation ("Ranaz") (TSX-V : RNZ), a company specialized in the manufacturing and marketing of protein and dietary supplements, reported its results today for the second quarter ended June 30, 2009.

Sales for the second quarter of 2009 totalled $5.7 millions as compared to $6.7 millions in the same quarter of 2008. Sales for the first six months of 2009 totalled $10.0 millions, down of $1.1 million or 9.8% as compared to the same period of 2008. The sales for Protidiet increased compare to the same quarter of 2008 due to the higher demand for our products in United States.

"Given the current macroeconomic environment that characterized the first half of 2009, we are proud that Protidiet sales continued to increase. This growth has enabled us to absorb the slowdown in sales for Protilife and Bartech. With the current backlog of orders, we can affirm that our customers are loyal and this should enable us to catch our sales forecast. "Said Jean Bourassa-Marineau, President and founder of Ranaz.

"During the second quarter, we completed the integration of the bar line. We took this opportunity to invest in our infrastructure products to make significant improvements. Our short term goal is to improve our daily production capacity. With the bars now in St-Eustache, the entire production team can now respond in real time. "Said Bernard Prévot, the Manufacturing Operations Manager.

The Company has net earnings of $368,108 or $0.008 per share for the second quarter of 2009, as compared to a net loss of $408,919 or $0.011 per share last year, which represent an increase of 190%. This decrease of the net loss was mainly attributable to the drop of selling expenses of 45.7% and the administrative expenses drop of 21.4%.